Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axisXiyang Tang(Jinan University), Jinbo Zhao(Air Force Medical University)Frontiers in ImmunologyOctober 4, 202210.3389/fimmu.2022.1014053Cited by 54SaveCiteExport RISWatch citationsRelated PapersNeoadjuvant Camrelizumab Plus Platinum-Based Chemotherapy vs Chemotherapy Alone for Chinese Patients With Resectable Stage IIIA or IIIB (T3N2) Non–Small Cell Lung Cancer|JAMA Oncology|2023|96<p>Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer</p>|OncoTargets and Therapy|2019|12